Caspase 3 and 7 Promote Cytoprotective Autophagy and DNA Damage Response in Human Breast Cancer Cells

Study Background and Research Question

Cellular adaptation to stress is crucial in both normal physiology and cancer. While caspases are classically associated with apoptotic cell death, emerging evidence suggests their involvement in non-lethal cellular processes. In the study by Samarasekera et al. (2025), the central question addressed is whether effector caspases—specifically caspase 3 (CASP3) and caspase 7 (CASP7)—play roles in regulating cytoprotective autophagy and DNA damage responses during sub-lethal stress in human breast cancer cells. This builds on prior Drosophila research where caspase-driven autophagy was observed, but extends the inquiry to the human cellular context, with direct implications for cancer therapy and metabolic stress adaptation.

Key Innovation from the Reference Study

The principal innovation of this research is the demonstration that CASP3 and CASP7 are not merely apoptotic executors but act as positive regulators of cytoprotective autophagy and DNA repair signaling under non-lethal stress conditions. Specifically, the authors show that depletion of both caspases disrupts autophagy and impairs phosphorylation of H2AX, a key marker of DNA damage response, while increasing PARP1 cleavage. Notably, they identify a novel, calpain-dependent processing pathway for CASP7 during stress, resulting in stable p29/p30 fragments that restore DNA damage signaling even in caspase-deficient backgrounds. This expands the paradigm of caspase biology, linking it directly to adaptation mechanisms critical for cancer cell survival under therapeutic or metabolic stress.

Methods and Experimental Design Insights

The investigators used a combination of genetic and biochemical approaches in human breast cancer cell lines subjected to non-lethal stressors such as nutrient deprivation and proteasome inhibition. Key methodological highlights include:

• CRISPR/Cas9-mediated knockout of CASP3 and CASP7, individually and in combination, to dissect their distinct and overlapping roles.
• Assessment of autophagy markers (LC3B, ATG7) at mRNA and protein levels.
• Detection of DNA damage response via γH2AX (phosphorylated H2AX) immunoblotting.
• Analysis of PARP1 cleavage as an indicator of cellular stress response and caspase-PARP1 crosstalk.
• Characterization of CASP7 processing events using protease inhibitors and mutational analyses to map calpain cleavage sites.
• Rescue experiments reintroducing CASP7-p29/p30 fragments into double knockout cells to confirm their sufficiency for DNA damage signaling restoration.

The study design enabled precise dissection of stress adaptation pathways, with appropriate controls and multiple stress paradigms, strengthening the validity of the observed phenomena.

Core Findings and Why They Matter

Central findings from the reference study include:

• Loss of both CASP3 and CASP7 resulted in significantly decreased autophagic markers (LC3B, ATG7) and impaired H2AX phosphorylation, indicating blockade of both autophagy and DNA repair signaling under non-lethal stress.
• Enhanced PARP1 cleavage in double knockouts suggests a regulatory axis between caspase activity and PARP1-driven stress response, with implications for NAD+ as a substrate in these pathways.
• Calpain-mediated, non-canonical CASP7 processing during stress generates stable fragments (p29/p30) that are both necessary and sufficient to restore DNA damage signaling in caspase-deficient cells.
• Loss of CASP3 and CASP7 is synthetically lethal with BRCA1 deficiency, indicating potential vulnerabilities that could be therapeutically targeted in certain breast cancer subtypes.

These results challenge the prevailing dogma that caspases are solely destructive enzymes, and instead position them as integrators of metabolic, autophagy, and DNA repair networks that are essential for cancer cell survival during moderate stress. This reframing has important implications for interpreting the outcomes of metabolic signaling and autophagy assays, especially when considering experimental manipulations of caspase or PARP activity.

Comparison with Existing Internal Articles

The findings of Samarasekera et al. are complementary to recent advances in the understanding of metabolic stress and autophagy regulation. For example, the article "AMPK Suppresses Autophagy Initiation During Energy Stress" overturns the traditional model of AMPK as a universal autophagy activator, revealing its context-dependent inhibitory effects. This aligns with the reference study's emphasis on non-canonical regulatory mechanisms driving autophagy and stress adaptation. Similarly, "NAD+ as a Dynamic Regulator in Metabolic Signaling and Energy Stress" discusses how Nicotinamide Adenine Dinucleotide (NAD+) participates in both metabolic signaling and as a substrate for enzymes like PARP1, which is directly implicated in the caspase-PARP1 axis described by Samarasekera et al. These converging lines of evidence underscore the complexity of stress response pathways and highlight the value of integrating insights from both metabolic and proteolytic regulatory systems.

Limitations and Transferability

Despite its strengths, the study is limited by its primary focus on human breast cancer cell lines and in vitro stress paradigms. The functional relevance of caspase-mediated autophagy and DNA repair in vivo, and across different tissue types or cancer subtypes, remains to be fully elucidated. The observed synthetic lethality with BRCA1 loss is promising, but further work is needed to determine whether this vulnerability can be robustly targeted in clinical contexts. Additionally, while the relationship between caspases, PARP1, and NAD+ metabolism is intriguing, the mechanistic details of how NAD+ pools and turnover impact these adaptive responses require further investigation, particularly in light of the product’s use as a substrate for both sirtuins and PARPs.

Protocol Parameters

• CRISPR/Cas9 knockout: Generate single or double knockouts of CASP3 and CASP7 to dissect effector roles in stress adaptation.
• Non-lethal stress induction: Apply nutrient deprivation or proteasome inhibitors at sub-lethal doses to trigger adaptive, not apoptotic, responses.
• Assessment of autophagy flux: Monitor LC3B lipidation and ATG7 expression as readouts for autophagy initiation and progression.
• DNA damage response: Use γH2AX as a marker for DNA double-strand break signaling; combine with PARP1 cleavage assays to evaluate pathway crosstalk.
• Protease inhibitors: Employ calpain inhibitors to dissect non-canonical caspase processing events.
• NAD+ supplementation: For metabolic signaling and PARP1-dependent assays, supplement culture media with freshly prepared NAD+ solutions to ensure substrate availability and experimental consistency, as recommended in product documentation.

Research Support Resources

Researchers aiming to replicate or extend these findings can leverage specialized reagents to optimize metabolic signaling and autophagy workflows. Notably, Nicotinamide Adenine Dinucleotide (NAD+) (SKU B1793) from APExBIO is highly soluble and suitable for use in enzymatic assays involving PARP1, sirtuins, and related metabolic pathways, as described in the internal workflow guide. When incorporating NAD+ into experiments, it is best to prepare solutions freshly and use them promptly to avoid degradation, enabling robust interrogation of NAD+-dependent signaling in the context of stress adaptation and DNA repair.